Let's spread the word about Immunotherapy! Click to share this page with your community.

The CRI Cancer Immunotherapy Consortium (CIC) contributes to the creation of white papers, response documents, and peer-reviewed publications advancing novel outcomes from workshops that seek practical solutions to today's challenges in cancer immunotherapy development.


Publications prior to 2010 are credited to the Cancer Vaccine Consortium, the former name of the Cancer Immunotherapy Consortium.


A browser plugin may be required for the PDF file found this page.

*Immunotherapy results may vary from patient to patient.